TAI · 6446.TW
PharmaEssentia Corporation
NT$1,190.00-NT$50.00 (-4.03%)
PharmaEssentia Corporation’s quoted price sits in the upper half of its reported 52-week range, 27.66% below the high.
Loading market information…
TWO · 6569.TWO · TWD
Stock price, dividends, earnings
Quote as of Oct 30, 2026, 05:30 AM UTC. Cached market data; not a live quote.
One-year closing-price history · TWD. Historical prices are not a forecast.
Onyx Healthcare Inc.’s quoted price sits in the lower half of its reported 52-week range, 32.17% below the high.
52-week range
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
THE INCOME SIDE
Onyx Healthcare Inc.’s forward annual dividend is NT$3.00 per share, paid annual. The forward yield is 3.43% at the quoted price. Future payments can change.
Historical amounts are adjusted for stock splits. Understand ex-dividend and payment dates →
BEHIND THE RESULTS
Upcoming dates and analyst estimates may change. Fiscal quarters follow Onyx Healthcare Inc.’s reporting calendar.
THE COMPANY BEHIND THE TICKER
Onyx Healthcare Inc. is a dedicated Taiwanese firm specializing in medical information technology. The company focuses on the entire lifecycle—from conceptual design and manufacturing to the commercial distribution—of medical computing hardware and peripherals, primarily targeting the hospital and clinical IT markets within Taiwan. Their extensive product lineup encompasses a variety of advanced solutions, such as AI-enabled medical PCs and tablets, specialized computer and monitor setups for digital operating rooms and telemedicine, and adaptable medical cart computers. They also offer robust medical power panel PCs, power banks, and sophisticated battery management systems. Further offerings include portable medical tablets, professional slim and powerful all-in-one PCs, medical displays and integrated computing solutions for medical devices, as well as motherboards and industrial-grade PCs and tablets, alongside healthcare infotainment systems. In addition to their core products, Onyx Healthcare provides custom Original Design Manufacturing (ODM) and Original Equipment Manufacturing (OEM) services. Established in 2010, the company is headquartered in New Taipei City, Taiwan, and operates as a subsidiary of AAEON Technology Inc.
Latest available per-share figures in TWD. The payout ratio compares dividends with earnings.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Oct 30, 2026, 12:27 PM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
Completed calendar years and any current-year payments shown separately. Current-year totals are incomplete until all payments are made.
See annual income at the current dividend rate.
Assumes the annual dividend stays unchanged. Payments follow the company’s schedule. Excludes taxes, fees and currency changes.
| NT$299.34M-17.54% vs estimate |
| Q1 2024 | May 8, 2024 | NT$1.32+67.51% vs estimate | NT$275.34M-15.02% vs estimate |
|---|
| Q4 2023 | Feb 27, 2024 | NT$1.73-6.49% vs estimate | NT$434.80M-2.51% vs estimate |
|---|
HOW THE BUSINESS IS PERFORMING
Statement amounts use the company’s reporting currency and are not converted to the stock’s listing currency. K = thousand, M = million, B = billion, T = trillion. Cash-flow figures are matched by fiscal year; missing figures appear as a dash.
PUT THE NUMBERS IN CONTEXT
Current metrics alongside available historical medians. A lower multiple or higher margin alone does not establish whether a stock is a good investment.
KEEP COMPARING
NT$1,190.00-NT$50.00 (-4.03%)
PharmaEssentia Corporation’s quoted price sits in the upper half of its reported 52-week range, 27.66% below the high.
NT$159.00-NT$2.50 (-1.55%)
Lin BioScience, Inc.’s quoted price sits in the upper half of its reported 52-week range, 23.19% below the high.
NT$39.05-NT$1.75 (-4.29%)
Pell Bio-Med Technology Co., Ltd.’s quoted price sits in the lower half of its reported 52-week range, 97.38% below the high.
NT$379.00-NT$13.00 (-3.32%)
Bora Pharmaceuticals Co., Ltd.’s quoted price sits in the lower half of its reported 52-week range, 41.78% below the high.
NT$167.50-NT$5.00 (-2.9%)
Lotus Pharmaceutical Co., Ltd.’s quoted price sits in the lower half of its reported 52-week range, 54.67% below the high.
NT$31.45+NT$0.55 (+1.78%)
DIVA Laboratories, Ltd.’s quoted price sits in the lower half of its reported 52-week range, 16.8% below the high.
NT$90.50NT$0.00 (0.0%)
Acer Medical Inc.’s quoted price sits in the lower half of its reported 52-week range, 29.3% below the high.
NT$18.05+NT$0.05 (+0.28%)
EBM Technologies Incorporated’s quoted price sits in the lower half of its reported 52-week range, 27.66% below the high.
